SCHEMBL6570685

SCHEMBL6570685

COc1ccc(CCCCc2cc[c]cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.58
IGF1R P08069 1/20 0.56
ALOX15 P16050 1/20 0.56
TAAR1 Q96RJ0 1/20 0.53
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ALOX5 P09917 1/20 0.49
MAOB P27338 2/20 0.48
SIGMAR1 Q99720 1/20 0.47
AOC3 Q16853 1/20 0.47
IDO1 P14902 1/20 0.47
F2RL1 P55085 1/20 0.46
TUBB4A P04350 1/20 0.46
TUBB P07437 1/20 0.46
TUBA3C P0DPH7 1/20 0.46
TUBA1B P68363 1/20 0.46
TUBA4A P68366 1/20 0.46
TUBB4B P68371 1/20 0.46
TUBB3 Q13509 1/20 0.46
TUBB2A Q13885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6568496 0.96 CALM1 (0.63) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL9864385 0.92 TAAR1 (0.57) CALM1ALOX15TAAR1MAOBSIGMAR1
SCHEMBL27496419 0.90 TAAR1 (0.55) CALM1ALOX15TAAR1MAOBSIGMAR1
SCHEMBL4254058 0.87 CALM1 (0.72) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL28164121 0.85 CASP3 (0.47) CALM1IGF1RALOX15TDP1L3MBTL1
SCHEMBL10571532 0.85 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL11007798 0.85 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL9509173 0.85 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL17400406 0.85 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1
SCHEMBL28218193 0.85 CALM1 (0.69) CALM1IGF1RALOX15TAAR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1404325-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2004-04-07 EP disclosed
WO-2002096420-A2 METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY GUILFORD PHARMACEUTICALS INC. (US) 2002-12-05 WO disclosed
EP-1127049-A1 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL Holdings, Inc. (US) 2001-08-29 EP disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-2000016603-A2 BRIDGED HETEROCYCLIC DERIVATIVES GPI NIL HOLDINGS, INC. (US) 2000-03-30 WO disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed